These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

799 related articles for article (PubMed ID: 19280995)

  • 1. Human paraoxonase gene polymorphisms and coronary artery disease risk.
    Mendonça MI; Dos Reis RP; Freitas AI; Sousa AC; Pereira A; Faria P; Gomes S; Silva B; Santos N; Serrão M; Ornelas I; Freitas S; Araújo JJ; Brehm A; Cardoso AA
    Rev Port Cardiol; 2008 Dec; 27(12):1539-55. PubMed ID: 19280995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene-gene interaction affects coronary artery disease risk.
    Mendonça MI; Dos Reis RP; Freitas AI; Sousa AC; Pereira A; Faria P; Gomes S; Silva B; Santos N; Serrao M; Ornelas I; Freitas S; Freitas C; Araújo JJ; Brehm A; Cardoso AA
    Rev Port Cardiol; 2009 Apr; 28(4):397-415. PubMed ID: 19634497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PON1 M/L55 mutation protects high-risk patients against coronary artery disease.
    Oliveira SA; Mansur AP; Ribeiro CC; Ramires JA; Annichino-Bizzacchi JM
    Int J Cardiol; 2004 Mar; 94(1):73-7. PubMed ID: 14996478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperhomocysteinemia, paraoxonase activity and risk of coronary artery disease.
    Kerkeni M; Addad F; Chauffert M; Chuniaud L; Miled A; Trivin F; Maaroufi K
    Clin Biochem; 2006 Aug; 39(8):821-5. PubMed ID: 16875684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship between paraoxonase 1 55 Met/Leu, paraoxonase 2 148 Ala/Gly genetic polymorphisms and coronary artery disease].
    Chi DS; Ling WH; Ma J; Xia M; Hou MJ; Wang Q; Zhu HL; Tang ZH; Yu XP
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Jun; 23(3):289-93. PubMed ID: 16767666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischemic stroke.
    Can Demirdöğen B; Türkanoğlu A; Bek S; Sanisoğlu Y; Demirkaya S; Vural O; Arinç E; Adali O
    Clin Biochem; 2008 Jan; 41(1-2):1-9. PubMed ID: 17920578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effects between Q192R polymorphism of paraoxonase 1 gene and some conventional risk factors in premature coronary artery disease.
    Balcerzyk A; Zak I; Krauze J
    Arch Med Res; 2007 Jul; 38(5):545-50. PubMed ID: 17560461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of homocysteine thiolactonase activity and PON1 polymorphisms with the severity of acute coronary syndrome.
    Koubaa N; Nakbi A; Hammami S; Attia N; Mehri S; Ben Hamda K; Ben Farhat M; Miled A; Hammami M
    Clin Biochem; 2009 Jun; 42(9):771-6. PubMed ID: 19269283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The relationship between paraoxanase gene Leu-Met (55) and Gln-Arg (192) polymorphisms and coronary artery disease].
    Taşkiran P; Cam SF; Sekuri C; Tüzün N; Alioğlu E; Altintaş N; Berdeli A
    Turk Kardiyol Dern Ars; 2009 Oct; 37(7):473-8. PubMed ID: 20098041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined impact of matrix metalloproteinase-3 and paraoxonase 1 55/192 gene variants on coronary artery disease in Turkish patients.
    Ozkök E; Aydin M; Babalik E; Ozbek Z; Ince N; Kara I
    Med Sci Monit; 2008 Oct; 14(10):CR536-42. PubMed ID: 18830194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age and hypertension related changes in genotypes of MTHFR 677C>T, 1298A>C and PON1 -108C>T SNPs in men with coronary artery disease (CAD).
    Strauss E; Głuszek J; Pawlak AL
    J Physiol Pharmacol; 2005 Mar; 56 Suppl 2():65-75. PubMed ID: 16077191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal exposure to floricultural work during pregnancy, PON1 Q192R polymorphisms and the risk of low birth weight.
    Moreno-Banda G; Blanco-Muñoz J; Lacasaña M; Rothenberg SJ; Aguilar-Garduño C; Gamboa R; Pérez-Méndez O
    Sci Total Environ; 2009 Oct; 407(21):5478-85. PubMed ID: 19646734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Smoking enhances the decrease of adiponectin level in patients with coronary artery disease, carriers of MTHFR 677T and PON1 55M alleles].
    Strauss E; Radziemski A; Głuszek J; Pawlak A
    Przegl Lek; 2010; 67(10):859-65. PubMed ID: 21360915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of paraoxonase-192 polymorphism with low HDL-cholesterol in coronary artery disease risk.
    Mendonça MI; Dos Reis RP; Freitas AI; Pereira A; Sousa AC; Freitas S; Ornelas I; Freitas C; Brehm A; Araújo JJ
    Rev Port Cardiol; 2010 Apr; 29(4):571-80. PubMed ID: 20734577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraoxonase gene Gln192Arg (Q192R) polymorphism is associated with coronary artery spasm.
    Ito T; Yasue H; Yoshimura M; Nakamura S; Nakayama M; Shimasaki Y; Harada E; Mizuno Y; Kawano H; Ogawa H
    Hum Genet; 2002 Jan; 110(1):89-94. PubMed ID: 11810302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraoxonase polymorphisms PON1 192 and 55 and longevity in Italian centenarians and Irish nonagenarians. A pooled analysis.
    Rea IM; McKeown PP; McMaster D; Young IS; Patterson C; Savage MJ; Belton C; Marchegiani F; Olivieri F; Bonafe M; Franceschi C
    Exp Gerontol; 2004 Apr; 39(4):629-35. PubMed ID: 15050299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylenetetrahydrofolate reductase gene, homocysteine and coronary artery disease: the A1298C polymorphism does matter. Inferences from a case study (Madeira, Portugal).
    Freitas AI; Mendonça I; Guerra G; Brión M; Reis RP; Carracedo A; Brehm A
    Thromb Res; 2008; 122(5):648-56. PubMed ID: 18384842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A preliminary study of human paraoxonase and PON 1 L/M55-PON 1 Q/R 192 polymorphisms in Turkish patients with coronary artery disease.
    Kaman D; Ilhan N; Metin K; Akbulut M; Ustündağ B
    Cell Biochem Funct; 2009 Mar; 27(2):88-92. PubMed ID: 19226538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PON1 activity and genotype in patients with arterial ischemic stroke and in healthy individuals.
    Schiavon R; Turazzini M; De Fanti E; Battaglia P; Targa L; Del Colle R; Fasolin A; Silvestri M; Biasioli S; Guidi G
    Acta Neurol Scand; 2007 Jul; 116(1):26-30. PubMed ID: 17587252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paraoxonase gene polymorphism and serum activity in progressive IgA nephropathy.
    Kovács TJ; Harris S; Vas TK; Seres I; Short CD; Wittmann IK; Paragh G; Mackness MI; Mackness B; Durrington PN; Nagy JM; Brenchley PE
    J Nephrol; 2006; 19(6):732-8. PubMed ID: 17173245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.